A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
Francisco J PasquelM Cecilia LansangAmeer KhowajaM Agustina UrrutiaSaumeth CardonaBonnie AlburyRodolfo J GalindoMaya FayfmanGeorgia DavisAlexandra MigdalPriyathama VellankiLimin PengGuillermo E UmpierrezPublished in: Diabetes care (2020)
Hospital treatment with glargine U300 resulted in similar glycemic control compared with glargine U100 and may be associated with a lower incidence of clinically significant hypoglycemia.
Keyphrases
- glycemic control
- type diabetes
- blood glucose
- weight loss
- insulin resistance
- acute care
- healthcare
- minimally invasive
- risk factors
- mental health
- clinical trial
- palliative care
- coronary artery bypass
- randomized controlled trial
- adverse drug
- coronary artery disease
- emergency department
- phase ii
- adipose tissue
- phase iii
- combination therapy
- electronic health record
- replacement therapy
- drug induced